Ipravent Respules Nebulization

Ipratropium Bromide

500mcg/2ml

Cipla Ltd.

Pack size	2ml Respules x 20 (5's x4)
Dispensing mode	POM
Source	INDIA
Agent	NATIONAL TRADING AND PHARMACEUTICAL ESTABLISHMENT
Retail Price	21.00 AED

Available as:

40mcg - Inhalation (Dry Powder)

Indications

Ipravent Respules Nebulization is used for: Asthma, chronic obstructive pulmonary disease, chronic bronchitis, emphysema.

Adult Dose

Inhalation Asthma; Chronic obstructive pulmonary disease Adult: As Inhaler: Adults: 1-2 puffs (20 mg/puff) 3-4 times daily. Single doses of up to 80 mcg may be required in some patients. As nebulized soln 250-500 mcg 3-4 times daily.

Child Dose

Inhalation Asthma; Chronic obstructive pulmonary disease Child: As metered-dose aerosol: <6 yr 20 mcg tid; 6-12 yr 20-40 mcg tid. As soln for nebulisation: <6 yr For acute asthma: 125-250 mcg, given no more often than 6 hrly up to a total dose of 1 mg. 6-12 yr For acute and chronic asthma: 250 mcg, repeated as necessary up to a total dose of 1 mg.

Renal Dose

Administration

Contra Indications

Ipratropium Bromide solution should not be taken by patients with known hypersensitivity to atropine or its derivatives or to any other component of the product.

Precautions

Bladder neck obstruction, narrow-angle glaucoma or patients susceptible to glaucoma, prostatic hyperplasia. Protect patient's eyes from nebulised drug. Renal and hepatic impairment. Pregnancy, lactation, children, elderly.

Pregnancy-Lactation

Pregnancy category: B Lactation: Unknown whether drug is excreted in breast milk

Interactions

Increased toxicity with other anticholinergic drugs.

Adverse Effects

Side effects of Ipratropium Bromide : Dry mouth, urinary retention, buccal ulceration, paralytic ileus, headache, nausea, constipation, paradoxical bronchospasm, immediate hypersensitivity reactions (urticaria, angioedema), acute angle-closure glaucoma. Potentially Fatal: Anaphylactic reactions, atrial fibrillation, supraventricular tachycardia.

Mechanism of Action

Ipratropium bromide blocks the action of acetylcholine at parasympathetic sites in bronchial smooth muscle causing bronchodilation.

Note

Ipravent Respules 500mcg/2ml Nebulization manufactured by Cipla Ltd.. Its generic name is Ipratropium Bromide. Ipravent Respules is availble in United Arab Emirates. Farmaco UAE drug index information on Ipravent Respules Nebulization is not intended for diagnosis, medical advice or treatment; neither intended to be a substitute for the exercise of professional judgment.

Some other brands of Ipratropium Bromide :

Nasal Spray

Atrovent 0.03% ^0.3mg/ml

BOEHRINGER INGELHEIM (KARL THOMAE)

Nebulization

Atrovent 0.025% ^0.25mg/ml

Boehringer Ingelheim GmbH

Inhalation (Dry Powder)

IPRAVENT DP Caps ^40mcg

Cipla Ltd.

Inhaler / Aerosol

ATROVENT N ^20mcg/Dose

Boehringer Ingelheim Pharma GmbH & Co. KG

Nebulization

ATROVENT ^500mcg/2ml

Boehringer Ingelheim International GmbH